Frontlight ResearchEarly access
Trial site
Xi' AN No.1 Hospital
- 2running trials
The trials here
What the 2 trials at this site are about, from their registry records.
- Conditions
- Macular degeneration2 trials
- Phase
- Phase 31 trial
- Phase 41 trial
- Status
- Active, not recruiting1 trial
- Not yet recruiting1 trial
- Lead sponsor
- BioDlink Biopharm Co., Ltd.1 trial
- Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine1 trial
Running trials
Not yet recruiting
Active, not recruiting
TAB014 Compared to Lucentis® in Patients with Neovascular Age-related Macular Degeneration
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Macular degeneration1 recruiting
Site data: ClinicalTrials.govUpdated 12 Nov 2026